147 related articles for article (PubMed ID: 24613165)
1. Synthesis and in vitro evaluation of 12-(substituted aminomethyl) berberrubine derivatives as anti-diabetics.
Li R; Wu J; He Y; Hai L; Wu Y
Bioorg Med Chem Lett; 2014 Apr; 24(7):1762-5. PubMed ID: 24613165
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents.
Park KD; Lee JH; Kim SH; Kang TH; Moon JS; Kim SU
Bioorg Med Chem Lett; 2006 Aug; 16(15):3913-6. PubMed ID: 16730982
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and hypoglycemic activity of 9-O-(lipophilic group substituted) berberine derivatives.
Zhang S; Wang X; Yin W; Liu Z; Zhou M; Xiao D; Liu Y; Peng D
Bioorg Med Chem Lett; 2016 Oct; 26(19):4799-4803. PubMed ID: 27561717
[TBL] [Abstract][Full Text] [Related]
4. [8-hydroxy-dihydroberberine ameliorated insulin resistance induced by high FFA and high glucose in 3T3-L1 adipocytes].
Xu LJ; Lu FE; Yi P; Wang ZS; Wei SC; Chen G; Dong H; Zou X
Yao Xue Xue Bao; 2009 Nov; 44(11):1304-8. PubMed ID: 21355331
[TBL] [Abstract][Full Text] [Related]
5. Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes.
Zhou J; Zhou S
Eur J Pharmacol; 2010 Dec; 649(1-3):390-7. PubMed ID: 20868663
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of disaccharide modified berberine derivatives and their anti-diabetic investigation in zebrafish using a fluorescence-based technology.
Wang L; Kong H; Jin M; Li X; Stoika R; Lin H; Liu K
Org Biomol Chem; 2020 May; 18(18):3563-3574. PubMed ID: 32347284
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of chalcone derivatives as potential anti-diabetic agents.
Hsieh CT; Hsieh TJ; El-Shazly M; Chuang DW; Tsai YH; Yen CT; Wu SF; Wu YC; Chang FR
Bioorg Med Chem Lett; 2012 Jun; 22(12):3912-5. PubMed ID: 22608392
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and biological activity of a series of benzopyran derivatives].
Tang L; Yang YS; Ji RY
Yao Xue Xue Bao; 2008 Feb; 43(2):162-8. PubMed ID: 18507343
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents.
Raza S; Srivastava SP; Srivastava DS; Srivastava AK; Haq W; Katti SB
Eur J Med Chem; 2013 May; 63():611-20. PubMed ID: 23567949
[TBL] [Abstract][Full Text] [Related]
10. Poliothrysoside and its derivatives as novel insulin sensitizers potentially driving AMPK activation and inhibiting adipogenesis.
Sashidhara KV; Singh SP; Varshney S; Beg M; Gaikwad AN
Eur J Med Chem; 2014 Oct; 86():570-7. PubMed ID: 25216379
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 9-substituted derivatives of berberine as anti-HIV agents.
Bodiwala HS; Sabde S; Mitra D; Bhutani KK; Singh IP
Eur J Med Chem; 2011 Apr; 46(4):1045-9. PubMed ID: 21295891
[TBL] [Abstract][Full Text] [Related]
12. Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.
Kim ED; Kim E; Lee JH; Hyun CK
Eur J Pharmacol; 2011 Jan; 650(1):479-85. PubMed ID: 20951125
[TBL] [Abstract][Full Text] [Related]
13. The design and synthesis of a novel compound of berberine and baicalein that inhibits the efficacy of lipid accumulation in 3T3-L1 adipocytes.
Hao M; Li Y; Liu L; Yuan X; Gao Y; Guan Z; Li W
Bioorg Med Chem; 2017 Oct; 25(20):5506-5512. PubMed ID: 28818460
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes.
Crane L; Anastassiadou M; El Hage S; Stigliani JL; Baziard-Mouysset G; Payard M; Leger JM; Bizot-Espiard JG; Ktorza A; Caignard DH; Renard P
Bioorg Med Chem; 2006 Nov; 14(22):7419-33. PubMed ID: 16889967
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis of phenyloxyisobutyric acid derivatives and their antidiabetic activity in vitro].
Zeng QL; Wang HQ; Luo H; Gao XP; Liu ZR; Li BG; Wang FP; Zhao YF
Yao Xue Xue Bao; 2006 Feb; 41(2):108-14. PubMed ID: 16671538
[TBL] [Abstract][Full Text] [Related]
16. A novel berberine-metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats.
Jia D; Li ZW; Zhou X; Gao Y; Feng Y; Ma M; Wu Z; Li W
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):533-544. PubMed ID: 30883863
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antihyperglycemic evaluation of various protoberberine derivatives.
Bian X; He L; Yang G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1380-3. PubMed ID: 16359864
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling.
Martinez L; Berenguer M; Bruce MC; Le Marchand-Brustel Y; Govers R
Biochem Pharmacol; 2010 May; 79(9):1300-9. PubMed ID: 20026082
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antifungal activity of a novel series of 13-(4-isopropylbenzyl)berberine derivatives.
Park KD; Cho SJ; Moon JS; Kim SU
Bioorg Med Chem Lett; 2010 Nov; 20(22):6551-4. PubMed ID: 20932752
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of 9-O-acyl- and 9-O-benzoyl-substituted berberrubines.
Hong SW; Kim SH; Jeun JA; Lee SJ; Kim SU; Kim JH
Planta Med; 2000 May; 66(4):361-3. PubMed ID: 10865456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
